Related Experiment Video

Updated: May 9, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and

David Gustafsson1, Robert Unwin

  • 1Bioscience, CVMD iMED, AstraZeneca R&D Mölndal, Mölndal, Sweden. david.gustafsson@astrazeneca.com

BMC Nephrology
|July 31, 2013
PubMed

Insights

High uric acid levels, known as hyperuricemia, are linked to gout and kidney stones. This review explores hyperuricemia

Area of Science:

  • Biochemistry and Human Metabolism
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Uric acid is the final product of purine metabolism in humans.
  • Elevated uric acid levels (hyperuricemia) are associated with gout and kidney stones (urolithiasis).
  • Hyperuricemia is increasingly implicated in cardiovascular disease and related conditions like hypertension, chronic kidney disease (CKD), congestive heart failure (CHF), metabolic syndrome, type 2 diabetes mellitus (T2DM), and atherosclerosis.

Purpose of the Study:

  • To review the metabolism of uric acid.
  • To summarize current literature on the role of hyperuricemia in cardiovascular disease and associated comorbidities.
  • To discuss emerging treatment strategies for hyperuricemia.

Main Methods:

  • Literature review of scientific articles and clinical studies.
  • Synthesis of existing research on uric acid metabolism and its clinical implications.
  • Analysis of data linking hyperuricemia to various health conditions.

Main Results:

  • Uric acid is a key indicator of purine metabolism.
  • Hyperuricemia is a significant risk factor for cardiovascular events and comorbidities.
  • Emerging treatments show promise in managing hyperuricemia and its related conditions.

Conclusions:

  • Understanding uric acid metabolism is crucial for managing associated diseases.
  • Hyperuricemia is a critical factor in the development and progression of cardiovascular and metabolic diseases.
  • Further research into novel therapeutic options for hyperuricemia is warranted.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...